Trial intelligence / Profile preview

Levothyroxine for subclinical hypothyroidism and lipid profile

IRCT20200731048259N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Lipid profile and Thyroid function tests. Started Dec 2021; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20200731048259N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200731048259N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call